Some family business

Readers of this blog will know that I am not the only scientist in the Elliott family, nor the best one.

My father Gerald, who pops up occasionally on this blog in the comments, or even from my mentioning him in the posts, (example here) published his first scientific paper back in 1957.

He emailed me earlier today to say that what he calls “my last experimental paper” – the data is a few years old, but has only just been written up – has just been accepted for publication in Cell Calcium.

As I told him, I reckon that publishing experimental science in seven different decades* is quite an achievement.

Congrats, mate.

 

——————————————————————–

*His last paper prior to this, an x-ray and neutron diffraction one from 2007, is here, with more listed here. And while I’m at it, I should also plug (again!) this historical account of some of his muscle work in the early 60s, which has some great pictures – including one of a 3 or 4 year old me.

 

Posted in History, The Life Scientific, Uncategorized | 10 Comments

Board of the Kings

In which I take stock, and decide to move on…

The world is changing: I feel it in the water, I feel it in the earth, and I smell it in the air.

…Though that last smell could be me, of course.

And I feel… old. Well… middle aged, anyway.

I am, of course, properly middle-aged, and even older than my esteemed colleague and occasional adversary Dr H Gee of this parish, another gentleman given to occasional musing on the onward thundering of Time’s Winged Chariot.

And I feel that, as the world changes, I need to follow suit.

As the two or three regular readers of this blog will know, I don’t kid myself that I am Mister-Height-of-Popularity with my employer. I have had the same job title now for more than twenty-four years – which might be the explanation, or might be the consequence…. who knows. Anyway, what with the way things are going in the UK Universities (see also here), I have decided it is probably time to make some changes.

One is that this blog is re-locating. It will be moving to a new site (to be announced) where it will be known henceforth as:

“A scientist does pawn”

…Which brings me to my second announcement.

I will be taking voluntary redundancy from my job at the University, and devoting myself full-time to attempting to become a chess master in my sixth decade.

The two or three regulars of this blog will know that I had a Dark Past, many, many Winters ago, as a Teenage Chess Fiend.

I have to blame Steve Caplan, and Stephen Moss, for helping to re-awaken the Dark Hunger in my soul for pawn, mating threats, combinatorial fireworks and zugzwang.

Now, chess is typically considered a young man’s game, but I think I can show these young whippersnappers that us Old Farts are not totally past it.

And in any case, since I gave up chess at the age of eighteen, in chess years I am not even twenty yet.

Getting back to the current day job, in the present financial climate all the UK Universities are keen to shed grumbling old geezers, so terms are on offer. With a bit of luck, the settlement should give me at least a year hunched over my chess books and my computer before I actually have to think of some way of earning a living. Hopefully not too honest a one.

For instance. I could make use of my knowledge of complementary medicine and join Cromercrox as a Celebrity Nutritionist.

And if that is not enough, I can always send The Boss out to work full time. The kids will both be in full-time education (or nursery, at least) from this coming September, so I could even become a chess-studying house-husband.

So…. this blog, in its new guise and home, will henceforth be cataloguing my progress in my new career (or rather non-career) direction. Though it may digress back into science from time to time.

Meanwhile, as a taste of things to come, here is a chess game from my long-ago Geek Years. Enjoy – especially the two Steves. Or stop reading, if you are pawn-averse.

————————————————————————————-

A Elliott – S Hughes
Oxford Inter-School League Match, Nov 1978

1. e4 e6
2. d4 d5
3. Nc3 Bb4

The Winawer variation of the French Defence (1…e6)

4. e5 c5
5. a3 Bc3: +
6. bc: Ne7

A typical starting position in the Winawer variation. 6 ..Ne7 allows Black to meet 7 Qg4 with castling King-side or perhaps with ..Ng6, if Black does not fancy the complications of 7. Qg4 Qc7 8. Qg7: Rg8 9. Qh7: cd: 10. Ne2 etc

7. Nf3

Opting for something a bit less manic, but not without teeth

7. ….h6

To prevent a later Ng5 if Black castles King-side

8. a4

An important move. White is planning to develop the Queen’s Bishop on a3 to take advantage of Black’s weakness on the dark squares.

8. …Qc7
9. Bd3 Bd7
10. 0-0 c4

A committal move, closing the centre. This usually signifies that Black intends to castle Queen-side and try and launch a pawn storm against the White King with the g- and h-pawns. However, it would be better to keep the tension in the centre a while longer with …Nbc6 and 0-0-0.

11. Be2 Nbc6
12. Ba3 0-0-0

The position is now set, a typical type in this opening, with a fairly fixed pawn centre and the players castled on opposite sides. Black plans his King-side attack, while White will attack on the Queen side down the a- and (open) b-files and on the Black squares. The question in such positions is always – who will get there first?

13. Nd2

Re-deploying the Knight toward the Queen-side.  It also means Black cannot gain time by attacking the Knight with g5-g4

13. …g5 (diagram)

Starting the planned advance.

After black's 13th move

White to play

14. Qb1 !

This looks a bit of a cumbersome way to get the Queen into action, but appearances can be deceptive.

14. …Rdf8 ?!

Black changes his plan, now deciding to try and open the f-file with f6. It would almost certainly have been better to stick to his first idea with Rdg8, h5, g4, h4 etc

15. a5 f6

White’s a-pawn cannot be taken, and Black does not want to block it with a6 as this would leave the b6 square weak

16. Bd6

Emphasising Black’s dark-squared weakness and also protecting the pawn on e5.

16.      …Qd8
17. Qb2

Intending Rfb1 with the threat of mate on b7

17.    …Nb8

An ugly move, but it makes space for the Bishop to go to c6 and protect b7

18. Rfb1 Bc6
19. Bc5

Forcing Black’s reply, which leaves b6 weak

19.     …a6 (diagram)

But now White has a nice tactical shot:

After black's 19th move

After 19... a6

20. Bc4:! fe:

Capturing the Bishop allows White’s Knight to c4, when the threats of Nb6+ or Nd6+ leave Black in dire straits, e.g. 20 …dc 21. Nc4: Nd5 22. Nd6+ Kd7 23 c4 or Nb7:

21. de: Nf5

The Bishop is still taboo

22. Bd3 Rf7
23. Bf5:

Deciding to remove Black’s only actively-placed minor piece

23. …Rf5:
24. Bd6 Nd7 (diagram)

Probably worrying about Nb3-c5-b7, but White has another way to pry open Black’s position.

White to play

After 24... Nd7

25. c4! g4

Trying for some counterplay with ..Qh4 and perhaps …Rh5

26. cd: Bd5:

Wanting to open the diagonal for the Bishop, with ideas like …Qh4 and if g3 …Qh3. – but Black is too late

27. Qc3+ Bc6
28. Ne4 Qh4 (diagram)

A desperate attempt to conjure up a threat, e,g, with ..Rh5, but allowing the decisive blow.

White to play

After 28...Qh4

29. Rb7: ! Kb7:
30. Rb1+ Bb5

30…Ka7 Qc6: is no better

31. Rb5:+ !

A second rook sacrifices itself to remove a defender

31.    …ab:
32. Qc7+ Ka6

And Black resigned, not waiting for 33 Nc5+ Nc5: 34 Qb6 mate (diagram).

The unreached final mate

 

Posted in Chess, Getting old, Uncategorized, Universities | 15 Comments

No surprises likely on UK University fees

To the surprise of pretty much nobody, either in the University or outside, my University has become the latest to announce that undergraduate tuition fees will rise to the full £ 9000 a year from 2012.

[Formal announcement from the Univ, noting that the higher fees will be combined with fee waiver and bursary schemes, and more outreach work, is here]

The fee announcement was widely anticipated, mainly because most people in the research-intensive English Universities predicted as soon as the Goverment’s announcements on fees were made back in the Autumn that all the “prestige” Universities would charge the maximum permissible £ 9000 across the board. For instance, I wrote in a comment somewhere back at the beginning of November:

“Though the Russell Group’s* statement does not say anything specific, one assumes their default position is likely to be to charge £ 9K across the board. At least, that would be my prediction.”

[*For non-UK readers, the Russell Group is made up of research-intensive, often older, UK Universities, including Oxford and Cambridge, Imperial, UCL, and most of the large “civic” Universities located in the UK’s major cities]

William Cullerne Bown over at Research Blogs (formerly named Exquisite Life) has a good analysis on “forecasting fees”. As he notes, the main question is really how many (or more likely how few) Universities in England will charge less than £ 9K per annum.

[Research Blogs are updating their list as more Universities announce their fee levels – latest version here. So far they are predicting that at least half the UK’s Universities will be setting their fees at the £ 9K maximum.]

The unspoken question is what will happen to student recruitment, and student numbers, once the fees go up. Of course, this is likely to be a question that “bites” differently in different institutions, and in different subjects. High end institutions, whose degree courses are harder to get onto, and whose degrees are valued higher by graduate recruitment for higher-paying careers, would clearly be predicted to face less fall-off in student numbers than institutions lower down the pecking order.

The next question is how the effects of fees will pan out across the subject spectrum. Scientists obviously wonder foremost about the sciences.

One argument is that numbers wanting degrees in sciences will be predicted to hold up better, since science degrees are seen to be more likely to lead to acceptably paid employment.

I wonder. In the biosciences, one could argue that job prospects in England look less than rosy at the moment. With the recent spate of announcements of cut-backs and redundancies in UK-based Pharma, scientific research jobs in the UK are on a clear downturn. The lack of real-terms growth in the research budget also means there are hardly going to be more jobs for graduate and postdoc researchers over the next few years.

In this context, Research Blogs also carries a sobering analysis of yesterday’s UK budget and the Government’s plans. Their take is that, for all the mentions of science, there is little or nothing concrete to make scientists more cheerful.

“So now that we have a more complete picture of the new government’s approach to science and technology, what we can say is that it almost certainly involves substantial cuts in spending at all stages. And whatever the short-term pressures, it is telling that there is no commitment to return to hi-tech support when the squeeze ends, no sign of the long-term support for science that the Royal Society and others have been arguing for.”

Now it may be true that, overall,  UK job prospects for people with scientific and numeracy skills will still remain better than for graduates in other disciplines, whatever the particular fate of the research sector. But that cannot really disguise the fact that, for most non-vocational degrees including scientific ones, graduate jobs are going to be harder to come by as the UK struggles to emerge from recession.  And pay in many of the jobs that are around is likely to be frozen, and thus declining in real terms in the face of rising inflation. So is it worth paying a lot of money to go to University if it is evidently less likely to lead to an adequately paid job than hitherto? Who will want to take on all that debt to become a nurse, for instance? Or a science teacher? Or an academic?!

Talking of student numbers generally, I reckon a fair number of academics in the UK might agree with the sentiment one hears expressed here and there that too many people currently go to University. We have essentially doubled entry to every science degree course we run in the last 15 years, as well as inventing degrees where previously there were none. The latter has often occurred by the “graduatizing” of previously largely non-graduate jobs  – e.g. this year at my University we admitted 300 or so students onto our Bachelor of Nursing degree, see above, which did not exist ten yrs ago.  But the number of students going to University is essentially a political decision in the UK. It has never really been in the Universities’ hands.

Of course, that might change. It is interesting to note that one of the things the UK Govt has been wholly silent on thus far (at least as far as I have heard)  is just how many places they are prepared to fund for those courses where they are still going to supply some of the teaching costs, e.g. in the sciences, or in medicine. There has been much talk on fees, but on student numbers… zip.

Finally, for people that work in Universities, students through the doors, and student fees in the bank, will mean jobs.  The unfairness of a system that will mean those of us who went to University essentially for free will now be teaching students paying upwards of ten grand a year, is not lost on anyone. But of course, people who work in Universities have bills to pay too. The general unhappiness with this state of affairs is one of the underlying threads of today’s industrial action by University academics in the UK.

Anyway, amid the uncertainties that remain, we can agree on one thing. Going to University in England is going to be much,  much more expensive for students, and for their families. How that will change the Universities remains to be seen.

Posted in News, Science policy, Uncategorized, Universities | 7 Comments

A cross-plug – but in a good cause

The latest issue of Physiology News, which I edit, is now up online.

I wouldn’t usually plug it so blatantly – I would simply plug it marginally more sneakily, of course – but this issue contains two articles that may be of interest to more than just physiologists.

One, on p 16, is by Dr Peter Wilmshurst, the British cardiologist who is (still) being sued by American medical devices company, NMT Medical. You can read some of the history of the case here – or for more detail you could try the BMJ.

In the new article, Wilmshurst describes some of what he and his family have been through in the last few years. It is a sobering account, and should remind us that reform of the English libel law, while much discussed, is not yet with us.

The second article, on a somewhat happier subject, is a personal appreciation, by one of his early PhD students, of the life and work of Robert “Bob” Edwards, the IVF pioneer who recently won the 2010 Nobel Prize for Physiology or Medicine. It starts on p 18, straight after the Wilmshurst article, and is accompanied by some wonderful photographs.

Bob Edwards can also be seen on the magazine cover. You might enjoy guessing what all the components of the cover image show.

Posted in History, Medicine, News, Uncategorized | 2 Comments

Checking homeopathy – fat chance

In which I get distracted. And even more geeky. (You’ll see why – keep reading.)

I am SO, SO BORED with homeopathy.

Really.

I would rather write about anything, practically. Like chess. Or films (movies to our US based readers).  Or… anything.

Even actual science.

Well, maybe not that. That is, after all, the day job

But anyway, I am heartily bored with homeopathy. A feeling, I have noticed, that is shared by other scientists who write about it.

Nonetheless, in a rather frantic week last week – our teaching semester is only three weeks old, and the bits I am responsible for are about one major foul-up away from unravelling – I managed to find a spare hour to pen a short email to the Medicines and Healthcare products Regulatory Agency or MHRA’s consultation on the labelling of homeopathic remedies.

Why did I bother?

I suppose it was because, like in many things I do, I’d already invested quite a bit of time in writing about homeopathy and I felt.. well…. sort of… obligated, somehow.

Anyway, here’s what I wrote:

————————————————————————————————————–

Dear….

I am a scientist and lecturer in bioscience, involved in physiological research and in teaching undergraduate students in medicine, other healthcare professions and in biological sciences. I also run a magazine,  Physiology News, for the Physiological Society, which is one of the UK’s learned scientific societies. In 2006 I was involved in helping draft the Physiological Society’s response to the MHRA’s proposed changes to the regulations on labelling of homeopathic products. I am, however, writing here in a personal capacity.

Austin Elliott

——————————————————————————————–

Response to consultation

The key point I wish to make is that there is no reasonable excuse for the MHRA label NOT informing the public, in clear language on the label, that homeopathic products contain no trace of the “ingredient” with which they are badged. Not to give the customer/buyer/patient this information is wholly misleading, and deprives the person of the information they require to make a fully informed decision about what they wish to take for their perceived healthcare needs. This flies in the face of all the principles of modern views on patient autonomy and decision-making, for which accurate and complete information is mandatory.

To defend this misleading labelling on the basis of safety, or “consumer choice”, seems to me to miss the point entirely. It is not sufficient simply to label “remedies” with phrases like “the 30C homeopathic dilution of”… Anyone NOT familiar with the homeopathic dilution system will inevitably conclude, I contend, that this means “dilute”, but will NOT infer that it means “no detectable ingredient present”, as is actually the case.

It is thus unequivocally wrong for the MHRA label to state, on a homoeopathic preparation (for example):

“Active Ingredient: Each pill contains 30C Arnica Montana”

– since there is NO active ingredient, and the pill contains NO Arnica montana. The MHRA label should instead state:

“Active Ingredient: None – contains no Arnica montana

Prepared in accordance with homoeopathic practice”

Conflict of interest statement: I have no financial interest in the manufacture or sale of homeopathic or any other natural remedy or altermative medicine.

——————————————————————————————————————–

[NB to blog readers: some parts of the email owe a debt to the excellent response to the MHRA consultation written by Prof John McLachlan, which I commend to your attention.]

Many people reading here will probably be aware of this particular discussion on how to label homeopathic potions, so I won’t re-hash it again. If you aren’t , you can get some of the background at David Colquhoun’s blog. Or you can read an editorial I wrote for Physiology News about this back in 2006.

————————————————————————————————————

And now for something completely different

Finally, to prove that I really WOULD rather write about chess than about homeopathy, and especially for the two Steves (Dr Caplan of this neighbourhood, and Prof Moss of UCL) here is a chess problem, taken from my long-ago Shameful Past as a teenage chess nerd.

The following position arose after White’s 29th move in a game A Elliott – AJ King, Southern Counties U-16 Tournament 1977 (Yes, really – and yes, it certainly is depressing to be this old. Need you ask?).

Position after 29. Nd4

White has just played 29. Nd4. The previous move-but-one black had played 27. …Be5, threatening the pawn advance …f4. The white Knight (which was already on d4) had gone to c6 (28. Nc6) to chase the Bishop away. Then 28…Bg7 and 29. Nd4.

There is thus a fairly obvious draw by repetition on offer – black could play 29. …Be5 again, then 30. Nc6 (30. Ne6 instead looks bad for white after 30. …Rg8) 30. …Bg7, 31. Nd4 Be5 etc.

However, black seemingly still had winning ambitions (he was the higher rated player) and instead played:

29. ….f4?!

30. Ne6 Be5 (diag)

Position after 30. ...Be5

The idea of …f4 and …Be5 is 31. Nf8: fg: + with attacking threats. Looking hard I think the attack should peter out, provided White does not blunder into a checkmate, but with both players short of time I didn’t really fancy it.

Luckily White has a neat way to defuse the threats and end up with a quietly won game. Can you see how?

Answer at the bottom.

Meanwhile….

…what to write about next? There is that more extended chess post I didn’t quite finish. The Steves might read that, even if no-one else does. Or perhaps if the family all come down with some tremendously nasty bug I can write about that, like the indefatigable MrDr H.G. of Cromer. Though, not having H.G’s devotion to the writerly craft, I suspect I would be too busy being ill. Or frantically washing my hands in obsessive-compulsive fashion. The state of the Universities in the UK is pretty much too depressing to write about. Ditto science funding. Ditto politics, from my perspective. So… History, perhaps?

Or just more procrastination?

*Sigh*

Or – any suggestions?

——————————————————————————————————————————

Answer: the game continued:

31 Qe5: + ! de: (if 31…Rf6 32. Nf4: if 31. …Qf6 32 Qf6: + & 33. Nf4; if 31. …Rg7 or 31. …Kg8 32. Nf8: and if 32. …de: 33. Ng6:) 32. Nf8: Qg4 33. Nd7:  …and with two Rooks and Knight for the Queen, White won easily.

Posted in Annoyances, Chess, Nerdishness, Pseudoscience | 26 Comments

More peer review. Zzzzzz.

In which, late as ever, I remember to say something about peer review.

There has been a bit of a flurry of commenting about peer review around OT just recently, with both RPG and Girl, Interrupting weighing in. The general consensus with them, and other bloggers, here, and most commenters on their posts, would be something like:

“Peer review: imperfect but necessary – and better than the alternatives”.

Now, I guess that would also broadly sum up my own view. I would add, I think, that peer review is more of a problem for grants than for papers. But, of course, this is more a function of the ludicrous success (or rather failure) rates for grant applications than of the refereeing process. More on that sort of stuff from me here, and in Stephen Curry’s recent post here.

Anyway, as I am feeling guilty (as usual) about not posting anything here for a while, I have disinterred what I wrote about peer review for an editorial in Physiology News a couple of years back (Autumn 2008, to be precise). Somewhat pompous and self-consciously “balanced” style, yada yada, but you’re used to that by now.

—————————————————————————————————————–

Peer review

Peer review, which lies at the heart of the scientific process, has a long history; the style of (‘single blind’) anonymous peer review now in common use was described by the Royal Society of Edinburgh in 1731, though the basic idea is far older. Despite this, widespread application of a system of anonymous expert referees did not become commonplace until later than is often believed, around the middle of the 20th century. Expert peer review in some form is now pretty much universal in scientific journals. So is there anything new to say?

Science vs non-science
One point that scientists sometimes need to remember is that peer review is not just important ‘internally’, but externally too. Properly functioning peer review is a key way to distinguish science from non-science (nonsense?). In a world where we are bombarded by apparently scientific claims – often for things that are being sold to us – it is important to have ways of telling sales talk and science apart, and peer review is one. As Sense About Science put it, peer review is an ‘essential arbiter of scientific quality’(1).

A fly in this ointment, of course, is that there is peer review and peer review. Journals in the top couple of dozen, or possibly more, journals in established subject categories – such as ‘physiology’ – maintain rigorous review processes, as we all regularly experience. But there are a lot of journals, and reviewing standards vary widely. As a recent report for the Publishing Research Consortium puts it (2):

‘Because the peer review standards of different journals vary, it is widely believed [by scientists] that almost any genuine academic manuscript, however weak, can find a peer-reviewed journal to publish it if the author is persistent enough.’

So, while publication in a peer review journal is some kind of quality mark, there is a blur at the edges.

Bibliometrics … inevitably
One way we might seek to clarify the reliability of work published in peer review journals are journal ‘pecking orders’, nowadays often substituted by bibliometric rankings. The most common of these, journal impact factors (IFs), while derided regularly and with plenty of justification, are clearly here to stay. As The Physiological Society’s journal editors put it a couple of years ago:

‘There is considerable divergence of opinion about the significance of [impact factors as a] measure of journal quality, but author surveys continue to confirm that a journal’s IF is among the most important considerations in choosing where to publish.’

That is, impact factor is a proxy for pecking order, and thus perhaps, to a limited extent, for reviewing standards. This may indeed be the only thing for which journal IFs are useful, since their worthlessness in assessing individual scientists and their work has been attested repeatedly, most  trenchantly by David Colquhoun (3).

Of course, journal IFs are only useful even in this restricted fashion within subject categories; their inadequacies when NOT comparing like with like are well described. While general science journals like Nature and Science have far higher IFs than journals like J Physiol and J Gen Physiol, I have yet to meet a single scientist in physiology who thinks that the reviewing at the general journals is more rigorous. To take another example, comparative physiology journals have notoriously low IFs, though the technical quality of the work they publish is high.

Can we improve anything about peer review?
While peer review is clearly vital, it is also imperfect; I suspect there is no scientist alive who does not have some complaint to recount. To their credit, journals try hard to ‘audit’ their review processes, and to tweak them in ways that will help them work better. The latest fashion seems to be for more explicit instructions to reviewers as to how to assess a paper and write a reviewer’s report. David Linden, the editor of the Journal of Neurophysiology, writes about this here (4), and Nature Cell Biology has also weighed in (5).

One thing I was glad to see in the latter was the exhortation to reviewers to ask ‘Are all claims made supported by the data?’ A personal view is that reviewers tend to be harder on whether they think experiments are technically correctly done – as Nature Cell Biol puts it: ‘Are key experiments or crucial controls missing? Are the data significant and definitive?’ – than on the inferences authors subsequently draw from the data. Though this is understandable, the danger here is that if an author repeats the same rather tenuous extrapolation in several published papers, they can then conceivably write a review citing all these papers and boosting tenuous extrapolation to the status of ‘well-tested hypothesis’ – next stop the textbooks. So a personal plea would be for reviewers to pay a bit more attention to what authors say in the Discussion, as well as in the Methods and Results.

This also brings me to a final point – what happens if you see a paper that clearly has something in it that is wrong, but that the journal’s referees have missed? It is certainly possible to write to the journal or its editors, though such letters rarely, in my experience, see the light of day.

My preferred solution to this problem is an electronic response thread following the online version of the article, something favoured by some medical journals and increasingly by exclusively
online journals. While it is perfectly possible to pen a short review commenting on a paper or papers, this rarely happens either, mostly for ‘activation barrier’ reasons. Writing a review, even a short one, is hard work. In contrast, penning an e-letter is a lot easier, and in the best cases generates quite an informative online debate. It is a bit like seeing the reviewing happening live, except after publication, and sometimes shows up things the journal reviewers missed. Another recent Nature Cell Biol editorial reveals that response threads will be coming soon for the Nature Group journals (6)  [Note: now in place, since this was written 2 yrs ago], and it will be interesting to see who else follows suit.

So to peer reviewers out there: keep up the reviewing standards, watch the authors’ extrapolations – and see you in an electronic response thread soon. Even after a few hundred years, this is no time to get sloppy.

1 “Peer review”. Sense About Science.
2 Peer Review: Benefits, perceptions and alternatives. Publishing Research Consortium.
3 Colquhoun D (2007). How to get good science. Phys News 69, 12–14. [online on his blog here]
4 Linden DJ (2008). Warm, fuzzy feeling. J Neurophysiol 100,1.
5 Good review (2008) Nature Cell Biol 10, 371.
6 What to publish? (2008). Nature Cell Biol 10, 247

[More hotlinks later if I can be bothered!]

————————————————————————————

So what would I add to that today?

Well, one thing is that, like the new President of the Royal Society in his Horizon TV programme the other night, I stand by the second paragraph – we need peer review. To those like me who spend a fair amount of time combating pseudoscience, it is absolutely clear that “serious” peer review, along the lines described above, remains one of the major differences between real science and the cargo cult stuff.

Unfortunately, the practitioners of many pseudosciences have got wise to this, and have set up their own journals. These too practice a kind of peer review – it is just that there it is review by your real peers, namely other people who have suspended their skepticism and critical faculties. Often this is done unknowingly, with people fooling themselves in their desire to believe – a kind of confirmation bias. But it is nonetheless a major problem, certainly in the area of complementary and alternative medicine (CAM).

There are certainly people who feel traditional pre-publication peer review should be replaced by something else, like “crowd source” peer review, or post-publication review. My friend David Colquhoun occasionally muses along these lines, and there are also vocal proponents like Cameron Neylon. I don’t think I am convinced. I am a fan of the idea of post-publication “crowd” review –see my words above. But I have my doubts about whether it is really workable.

One reason is that journals that do run online comments threads to allow “crowd response” tend to have rather little in the way of comments on many papers. Nature, for instance, only seems to attract comments on articles when the topic is something that gets the trolls and nuts in a frenzy, at which point the ratio of insane to rational comments tends to be about 10 (or more) to 1. For examples try, for instance, anything mentioning the fringe types who do not HIV is the cause of AIDS. That is not crowd review – more like spittle-flecked shouting.

The only journal I have seen thus far with an intermittently successful online comments set-up is the British Medical Journal, and even there it is patchy. Some articles do attract reasoned critique. Others, again, attract only the green ink brigade. Or, in the case of anything relating to vaccines, end up back where we just noted with Nature threads and HIV.

So in the end, I am back with the analogy that makes Cameron Neylon so tetchy. Yes, that Churchill one, about peer review being imperfect, but less imperfect than the alternatives.

Though we were discussing this after RPG’s post on peer review the other day, I hadn’t tracked down the real source of Churchill’s actual remark, which I will quote.

“Indeed, it has been said that democracy is the worst form of government except all those other forms that have been tried from time to time”

Per Wikiquotes, and via Cameron Neylon’s blog, the source is The Official Report, House of Commons – otherwise known as Hansard – (5th Series), 11 November 1947, vol. 444, cc. 206–07

Cameron Neylon makes the interesting point that the analogy we make between this and peer review is flawed, since alternatives to traditional peer review have not really been tried in the modern scientific era. And I think I would accept that that is a good reason to trial some alternatives, in a limited way. But until there is a really compelling body of evidence suggesting we dump pre-publication peer review, I shall be sticking to my take of Faute de mieux.

Posted in History, Peer review, Pseudoscience, Science policy, The Life Scientific | 8 Comments